downsized glp 1 Will We Stay on GLP-1 for Life? Our Honest Answer to a Big Question From supersize to downsize, GLP-1

Inflammatory Bowel Disease (IBD) and Crohns disease: BPC-157 has been found to reduce inflammation, restore gut mucosa, and prevent damage in experimental colitis models, making it a potential therapeutic agent for Crohns disease and ulcerative colitis (Seiwerth et al., 2014)

Fujita, H

You should discontinue use and seek medical attention if you experience persistent side effects lasting beyond 2-3 days, signs of liver problems, significant changes in blood pressure or heart rate, or any signs of an allergic reaction

The Role of NAD+ in Brain Health Peptides are not the only tool for brain optimization

Figure 1: Kaplan-Meier Curve for Overall Survival in KEYNOTE-189* *Based on the protocol-specified final OS analysis Initial Treatment in Combination with Cisplatin The efficacy of pemetrexed was evaluated in Study JMDB (NCT00087711), a multi-center, randomized (1:1), open-label study conducted in 1725 chemotherapy-naive patients with Stage IIIb/IV NSCLC